Man­u­fac­tur­ing roundup: Lon­za col­lab­o­rates with a VC in Is­rael; Pi­ra­mal up­dates one fa­cil­i­ty while open­ing a new one

The Swiss CD­MO pow­er­house Lon­za is no stranger to Is­rael, but a re­cent col­lab­o­ra­tion has ce­ment­ed a new hold over biotech in the re­gion.

Ac­cord­ing to the com­pa­ny, Lon­za and the Is­rael Biotech Fund, a ven­ture fund in­vest­ing in Is­raeli and Is­raeli-re­lat­ed biotech com­pa­nies, an­nounced a two-year frame­work agree­ment.

The deal aims to pro­vide ac­cel­er­at­ed time­lines for the de­vel­op­ment and man­u­fac­ture of bi­o­log­ics and small mol­e­cules. Lon­za will add sup­port to the IBF by work­ing to de-risk and pro­vide de­vel­op­ment and man­u­fac­tur­ing ser­vices to the IBF’s port­fo­lio com­pa­nies. The fi­nan­cial terms of the deal were not dis­closed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.